1
The global biosimilars market is expected to reach USD 13.1 billion by 2024 on account of an increase in the prevalence of chronic diseases such as cancer, diabetics, cardiac disorders, and autoimmune diseases. Rising demand for cost-effective therapies is expected to drive the market in the forecast period.

Comments

Who Upvoted this Story